Because of this controversy, we conducted a case-control study of the TGFBR1*9A/6A polymorphism, including mutational and ASE analyses, to clarify the effect of the TGFBR1*6A polymorphism on the risk of colorectal cancer in our population. This evidence concerns the gene TGFBR1 and colorectal cancer.